Followers | 437 |
Posts | 42954 |
Boards Moderated | 2 |
Alias Born | 05/08/2006 |
Friday, July 31, 2015 11:09:00 AM
GrowBLOX Sciences (“GB Sciences”) is a nature-inspired company employing a novel approach toward cannabis-based medicine. The company is focused on offering a turnkey business solution: transforming cannabis into safe and consistent medicine.
GB Sciences’ focus is on the research of indoor agriculture technology for the medical cannabis industry. The company merges state-of-the-art technologies in plant biology, cultivation and post-production processes in order to optimize safe, consistent medical cannabis. In doing so, the company is also pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm in order to bring relief to patients in communities across the country.
As part of its efforts to lock in industry standards, GB Sciences is developing a comprehensive line of highly effective cannabis-based therapies ranging from custom medical compounds to consumer health and beauty products. GB Sciences’ cultivation methodology ensures a consistent ratio of the plant’s medicinal properties for each and every harvest. This is a critical factor when creating formulations for standardized therapeutic products.
GB Sciences’ drug development program also endeavors to unlock the path to drug discovery and to provide novel cannabinoid therapies to patients with critically unmet needs. The company is developing the GrowBLOX system, a proprietary technology that allows for controlled growing conditions for the manufacture of toxin-free, natural, and medicinal-grade cannabis and cannabis concentrates. Starting with certified, cannabis plant-derived ingredients from the GrowBLOX technology suite, GB Sciences tests proprietary ratios of active ingredients in an accelerated drug development program. It also focuses on the research, testing and development of FDA-approved medical treatments and nutraceuticals using extracts from the cannabis sativa plant.
GrowBLOX Sciences is gearing up to cultivate the medical cannabis industry in new ways. The company’s science and research efforts power discovery, its engineering and design activities bring ideas into the real world, and its big data methodology drives continuous improvement.
For more information, visit the company’s website at www.growblox.com
Recent GBLX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:15:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:31:48 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2023 08:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:12:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2023 12:00:24 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM